Decision Change In Working Capital from 2010 to 2024
| DECN Stock | USD 0.0001 0.00 0.00% |
Change In Working Capital | First Reported 2010-12-31 | Previous Quarter 573.2 K | Current Value 544.6 K | Quarterly Volatility 946.8 K |
Check Decision Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Decision Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 32.9 M, Selling General Administrative of 2.6 M or Total Revenue of 1.7 M, as well as many indicators such as Price To Sales Ratio of 2.65, Ptb Ratio of 9.38 or Days Sales Outstanding of 182. Decision financial statements analysis is a perfect complement when working with Decision Diagnostics Valuation or Volatility modules.
Decision | Change In Working Capital |
Pair Trading with Decision Diagnostics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Decision Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decision Diagnostics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Decision Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Decision Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Decision Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Decision Diagnostics to buy it.
The correlation of Decision Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Decision Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Decision Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Decision Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Decision Diagnostics Correlation against competitors. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.